Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PARADIGM-Q Study: Development and Evaluation of a Culturally Sensitive Problem- and AttributesbAsed DIabetes Self-Management Program for People With Type 2 Diabetes Residing in Qatar

NCT06948370 is registered in ClinicalTrials.gov with Ragae Dughmosh as lead sponsor.

NCT NCT06948370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06948370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PARADIGM-Q Study: Development and Evaluation of a Culturally Sensitive Problem- and AttributesbAsed DIabetes Self-Management Program for People With Type 2 Diabetes Residing in Qatar
Lead sponsor
Ragae Dughmosh
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 20, 2025
Completion date
February 1, 2027
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes self-management, self-management, type 2 diabetes mellitus (t2dm)